CLDN11 and vibrio infectious disease: Therefore, in this current investigation, we assessed OSP-specific responses in animals orally primed with a licensed and available live attenuated oral cholera vaccine CVD 103-HgR and boosted with a cholera conjugate vaccine that contained OSP recovered from wild-type V. cholerae Inaba O1 conjugated to a recombinant heavy chain fragment of tetanus toxoid.20